机构地区:[1]Department of Medical Oncology,Hospital Professor Doutor Fernando Fonseca EPE,Amadora 2720-276,Portugal [2]Department of Medical Oncology,Centro Hospitalar Barreiro-Montijo EPE,Barreiro 2830-003,Portugal [3]Department of Medical Oncology,Hospital do Espírito Santo deÉvora EPE,Évora 7000-811,Portugal [4]Department of Medical Oncology,Centro Hospitalar Universitário do Algarve EPE,Algarve 8000-386,Portugal [5]Department of Medical Oncology,Hospital São Francisco Xavier,Centro Hospitalar Lisboa Ocidental EPE,Lisboa 1449-005,Portugal [6]Department of Medical Oncology,Hospital Santo António dos Capuchos,Centro Hospital Lisboa Central EPE,Lisboa 1169-050,Portugal [7]Department of Medical Oncology,Hospital BeatrizÂngelo,Loures 2674-514,Portugal [8]Department of Medical Oncology,Centro Hospitalar de Trás-os-Montes e Alto Douro EPE,Vila Real 5000-508,Portugal [9]Department of Medical Oncology,Hospital da Senhora da Oliveira EPE,Guimarães 4835-044,Portugal [10]Department of Medical Oncology,Hospital Garcia de Orta EPE,Almada 2805-267,Portugal [11]Department of Medical Oncology,Hospital da Luz,Lisboa 1500-650,Portugal [12]Department of Medical Oncology,Hospital Distrital de Santarém EPE,Santarém 2005-177,Portugal
出 处:《World Journal of Gastrointestinal Oncology》2022年第7期1307-1323,共17页世界胃肠肿瘤学杂志(英文版)(电子版)
摘 要:BACKGROUND Perioperative fluorouracil plus leucovorin,oxaliplatin,and docetaxel(FLOT)improves prognosis in locally advanced gastric cancer(LAGC).Neutrophil-to-lymphocyte(NLR),lymphocyte-tomonocyte(LMR),and platelet-to-lymphocyte(PLR)ratios are prognostic biomarkers but not predictive factors.AIM To assess blood ratios’(NLR,LMR and PLR)potential predictive response to FLOT and survival outcomes in resectable LAGC patients.METHODS This was a multicentric retrospective study investigating the clinical potential of NLR,LMR,and PLR in resectable LAGC patients,treated with at least one preoperative FLOT cycle,from 12 Portuguese hospitals.Means were compared through non-parametric Mann-Whitney tests.Receiver operating characteristic curve analysis defined the cut-off values as:High PLR>141 for progression and>144 for mortality;high LMR>3.56 for T stage regression(TSR).Poisson and Cox regression models the calculated relative risks/hazard ratios,using NLR,pathologic complete response,TSR,and tumor regression grade(TRG)as independent variables,and overall survival(OS)as the dependent variable.RESULTS This study included 295 patients(mean age,63.7 years;59.7% males).NLR was correlated with survival time(r=0.143,P=0.014).PLR was associated with systemic progression during FLOT(P=0.022)and mortality(P=0.013),with high PLR patients having a 2.2-times higher risk of progression[95% confidence interval(CI):0.89-5.26]and 1.5-times higher risk of mortality(95%CI:0.92-2.55).LMR was associated with TSR,and high LMR patients had a 1.4-times higher risk of achieving TSR(95%CI:1.01-1.99).OS benefit was found with TSR(P=0.015)and partial/complete TRG(P<0.001).Patients without TSR and with no evidence of pathological response had 2.1-times(95%CI:1.14-3.96)and 2.8-times(95%CI:1.6-5)higher risk of death.CONCLUSION Higher NLR is correlated with longer survival time.High LMR patients have a higher risk of decreasing T stage,whereas high PLR patients have higher odds of progressing under FLOT and dying.Patients with TSR and a pathological
关 键 词:Gastric cancer Perioperative fluorouracil plus leucovorin oxaliplatin and docetaxel Neutrophil-to-lymphocyte Lymphocyte-to-monocyte Platelet-to-lymphocyte Tumor regression grade
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...